Director, HCP Marketing - Medical Education and KOL Strategy, Alzheimer’s Disease Psychosis

Employer & Role Overview

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Summary:

Bristol Myers Squibb is building a leading Neuroscience franchise focused on addressing areas of significant unmet need across serious neuropsychiatric and neurodegenerative diseases. The Director, HCP Marketing, Medical Education, & KOL Strategy, Alzheimer's Disease Psychosis (ADP) will be responsible for developing and executing the U.S. KOL engagement strategy, medical education programming, peer-to-peer promotional activities, and congress commercial strategy for the anticipated launch of ADP, a potential first-in-class, first-approved treatment for AD psychosis and BMS’s inaugural commercial entry into Alzheimer's disease.

• KOL Engagement Strategy & Execution Develop and own the annual U.S. KOL engagement plan for ADP, including identification and tiered prioritization of thought leaders across the multi-specialty HCP landscape (psychiatrists, neurologists, geriatricians, geriatric psychiatrists, PCPs, NPs/PAs, and LTC medical directors) Build and manage trusted, long-term relationships with priority KOLs and emerging thought leaders, positioning BMS as a credible, science-forward partner in a new disease area for the company Partner closely with Medical Affairs (MSL team and Medical Directors) to ensure commercial and medical KOL engagement is coordinated, clearly delineated, compliant, and mutually reinforcing — maximizing the collective impact of BMS’s external scientific engagement Plan and execute commercial KOL programs, including advisory boards, promotional speaker development, and peer-to-peer educational events — ensuring timely insight capture and actionable readouts that inform brand strategy and planning Develop and maintain a KOL governance model, including goal-setting, tracking, and performance evaluation for KOL engagement activities
• Congress Planning & Execution Own the end-to-end U.S. commercial congress strategy and execution for ADP, across pre-launch and post-launch time frames and across priority medical congresses in neurology, psychiatry, geriatrics, LTC, and related fields (e.g., ADPD, IPA, AAIC, GAPNA, ASCP, GSA, ADCD, CTAD) Define and execute BMS’s commercial presence, messaging objectives, booth strategy, and HCP engagement activations at priority congresses, aligned to brand market shaping goals and the evolving ADP scientific platform Partner with Medical Affairs colleagues on symposia, CME programming, and scientific presentations to ensure commercial and medical objectives are integrated and mutually reinforcing at key congresses Manage all congress-related commercial logistics, vendor relationships, and activities on time, on budget, and in full compliance with BMS policies and applicable regulatory requirements Capture and synthesize insights from congress interactions and feed them back systematically into brand strategy and planning cycles
• Medical Education & Professional Promotion Develop and manage the professional promotional medical education strategy for ADP, including peer-to-peer programs, speaker bureau development and management, and HCP-facing educational content Oversee the development, review, and deployment of promotional and educational…